MustGrow Biologics More Than Triples Financing To $6.9 Million Due To Demand

Demand within the natural biopesticide space from investors appears to be extremely strong. MustGrow Biologics (CSE: MGRO) this morning expanded its previously announced $2.0 million private placement rather significantly, with the offering now pegged at $6.9 million.

The financing will now see a total of roughly 2.7 million units sold, at a price of $2.60 per unit. Each unit contains one common share and one full warrant, with warrants valid for a period of two years and pegged at $4.00 per share.

Notably, Ira Gluskin and related parties have agreed to invest $1.0 million into the financing, under the same terms and conditions. Gluskin most notably is the co-founder of Gluskin Sheff + Associates, a major wealth management firm, while also serving as a director for a number of advisory committees.

The financing will see proceeds utilized for the development of its pipeline as well as for working capital and general corporate purposes.

The offering is currently slated to close October 6.

MustGrow Biologics last traded at $2.87 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Critical Minerals Are Rerating! | John Passalacqua – First Phosphate

This Isn’t A Gold Rally. It’s A Warning! | Adrian Day

The U.S. Just Put Real Money Behind Critical Minerals | Simon Clarke – American Critical Minerals

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

MustGrow Sees Positive Results From Greenhouse Trials Against Root Rot Disease

MustGrow Biologics (CSE: MGRO) this morning reported the results of greenhouse trials with its mustard-derived...

Wednesday, May 12, 2021, 07:16:19 AM

MustGrow Biologics: Three Things To Know

MustGrow Biologics (CSE: MGRO) has been on a high volume tear as of late, with...

Wednesday, February 19, 2020, 12:21:45 PM

MustGrow Sees Executive From Impossible Foods Appointed To Board

MustGrow Biologics (CSE: MGRO) this morning had a major announcement, in that it has appointed...

Monday, December 14, 2020, 07:25:26 AM

MustGrow Conducts Successful Proof Of Concept For Mustard Derived Bio-Herbicide

MustGrow Biologics (CSE: MGRO) has successfully completed a proof-of-concept for its proprietary biological non-selective bio-herbicide....

Wednesday, August 12, 2020, 08:47:23 AM

MustGrow Biologics Sees Continued Positive Results From Field Trials For Banana Panama Disease

MustGrow Biologics (CSE: MGRO) has finally seen the results of its initial field trial program...

Wednesday, November 10, 2021, 08:01:52 AM